Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
0.960
-0.010 (-1.04%)
Dec 20, 2024, 4:00 PM EST - Market closed
Unity Biotechnology Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Unity Biotechnology stock has a target of 8.00, which predicts an increase of 733.51% from the current stock price of 0.96.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 8, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for UBX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +733.51% | Aug 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +733.51% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +733.51% | Apr 16, 2024 |
| Wedbush | Wedbush | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Nov 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +941.88% | Nov 14, 2023 |
Financial Forecast
Revenue This Year
58.58M
Revenue Next Year
78.28M
from 58.58M
Increased by 33.62%
EPS This Year
-1.50
from -2.70
EPS Next Year
-1.73
from -1.50
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 121.8M | 162.8M | 134.4M | |||
| Avg | 58.6M | 78.3M | 60.4M | |||
| Low | n/a | n/a | 24.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 177.8% | 71.7% | |||
| Avg | - | 33.6% | -22.8% | |||
| Low | - | - | -69.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.55 | -1.79 | -0.62 | |||
| Avg | -1.50 | -1.73 | -0.84 | |||
| Low | -1.46 | -1.68 | -1.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.